Compare Deutsche Bank AG (DB) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deutsche Bank AG vs Sana Biotechnology Inc — how do they compare? Deutsche Bank AG trades at $38.4 (market cap $71.96B), while Sana Biotechnology Inc trades at $3.78 (market cap $1.13B). The key difference: Deutsche Bank AG is far larger — about 63.7× Sana Biotechnology Inc's market cap, and Deutsche Bank AG pays a 3.04% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| DB | SANA | |
|---|---|---|
Market Cap | $71.96B | $1.13B |
Sector | Financials | Health |
52-Week High | $40.33 | $5.92 |
52-Week Low | $28.37 | $2.68 |
Dividend Yield | 3.04% | — |
Enterprise Value | — | $1.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Deutsche Bank AG
In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
